Elpiscience and Astellas partner for new macrophage engagers

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

Dec 28, 2023 - 18:00

Elpiscience and Astellas partner for new macrophage engagers

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new bispecific macrophage engagers for cancer.

Read the original article

Tags:

Previous Article

J&J jumps on ADC train, signs $1.7bn licensing deal with LegoChem

ARTBIO divulges plans for proprietary isotope manufacturing technology

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

MOMA Therapeutics and Roche sign cancer drug discovery deal

MOMA Therapeutics and Roche sign cancer drug discovery ...

Jan 5, 2024

Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an...

Feb 1, 2024

Opinion: Marc Tessier-Lavigne’s resignation shows what happens when you don’t pay attention to lab culture

Opinion: Marc Tessier-Lavigne’s resignation shows what ...

Jul 26, 2023